Medicare Enrolled
Dr. Joel Selter, M.D.
Optician · Suffern, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Selter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Selter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Selter
Dr. Joel Selter is an optician specialist in Suffern, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Selter performed 15,070 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Selter received a total of $85,734 from 32 pharmaceutical and/or device companies across 642 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Selter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 4% volume in NY
$85,734 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗15,070
Medicare services
Top 4% in NY for optician
Not available
Unique patients (not deduplicated)
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Omalizumab injection (Xolair) for asthma/allergy | 8,206 | $30 | $80 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
2,275 | $4 | $22 |
| Allergy skin patch test A diagnostic test where small amounts of potential allergens are applied to the skin to identify substances that cause an allergic reaction. |
1,255 | $5 | $30 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
630 | $11 | $68 |
| Allergy immunotherapy preparation A professional service involving the preparation and administration of one or more antigens. |
570 | $14 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
467 | $80 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
404 | $13 | $76 |
| Skin allergy test A test where small amounts of potential allergens are injected into the skin to check for allergic reactions. |
328 | $8 | $27 |
| Allergy test using drug or biological combination A diagnostic procedure to identify allergic reactions by testing a combination of methods using a specific drug or biological agent. |
252 | $19 | $52 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
152 | $116 | $450 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
87 | $36 | $248 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
85 | $18 | $60 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
73 | $35 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
61 | $103 | $525 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
52 | $8 | $45 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $145 | $675 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
35 | $36 | $75 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
30 | $72 | $98 |
| Allergy test using ingested items, initial 2 hours This procedure involves testing for allergies by having the patient ingest specific items over an initial two-hour period. |
25 | $113 | $600 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $51 | $150 |
| Allergy test using ingested items, each additional hour This procedure involves testing for allergies by having the patient ingest specific items. The code applies to each additional hour of the testing session beyond the initial period. |
13 | $78 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$85,734
Total received (2018-2024)
Avg $12,248/year across 7 years
Top 4% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
642
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$16,581
2023
$9,713
2022
$12,731
2021
$13,609
2020
$3,310
2019
$13,703
2018
$16,088
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$11,869
Grifols USA, LLC
$2,759
CSL Behring
$335
GlaxoSmithKline, LLC.
$293
GENZYME CORPORATION
$235
Takeda Pharmaceuticals U.S.A., Inc.
$204
Novartis Pharmaceuticals Corporation
$191
Pharming Healthcare, Inc.
$116
Regeneron Healthcare Solutions, Inc.
$92
PFIZER INC.
$89
Genentech USA, Inc.
$71
Blueprint Medicines Corporation
$71
BioCryst US Sales Co., LLC
$59
Cycle Pharmaceuticals Inc
$56
SANOFI-AVENTIS U.S. LLC
$55
Optinose US, Inc.
$32
kaleo, Inc.
$23
ALK-Abello, Inc
$15
Amgen Inc.
$15
Top 3 companies account for 90.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$72,236
Grifols USA, LLC
$3,116
Circassia Pharmaceuticals Inc
$2,406
GlaxoSmithKline, LLC.
$1,318
CSL Behring
$1,143
GENZYME CORPORATION
$757
Takeda Pharmaceuticals U.S.A., Inc.
$553
PFIZER INC.
$495
Regeneron Healthcare Solutions, Inc.
$471
Novartis Pharmaceuticals Corporation
$429
BioCryst US Sales Co., LLC
$380
kaleo, Inc.
$325
Pharming Healthcare, Inc.
$285
Genentech USA, Inc.
$251
Amgen Inc.
$192
Teva Pharmaceuticals USA, Inc.
$185
ALK-Abello, Inc
$178
Next Science LLC
$150
Blueprint Medicines Corporation
$142
Covis Pharma GmBH
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
OptiNose US, Inc.
$102
Shire North American Group Inc
$58
Incyte Corporation
$56
Cycle Pharmaceuticals Inc
$56
SANOFI-AVENTIS U.S. LLC
$55
Merck Sharp & Dohme LLC
$46
Optinose US, Inc.
$46
Covis Pharma B.V.
$42
Aimmune Therapeutics, Inc.
$23
NOVARTIS PHARMACEUTICALS CORPORATION
$16
Merck Sharp & Dohme Corporation
$15
Top 3 companies account for 90.7% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ALVESCO · AUVI-Q · AYVAKIT · BREO · CINQAIR · CINRYZE · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EUCRISA · FASENRA · Fabhalta · GLASSIA · Gamunex-C · HYQVIA · Haegarda · Hizentra · NIOX VERO DEVICE · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PREVNAR 20 · Prolastin-C Liquid · QVAR · RUCONEST · SPIRIVA RESPIMAT · SYMBICORT · Sajazir · SurgX · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
3,074
County median income
$110,631
Nearest hospital to ZIP centroid (approximate)
GOOD SAMARITAN HOSPITAL OF SUFFERN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Selter is a mixed practice specialist, with above-average Medicare volume (top 4% in NY), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Selter experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Selter performed 8,206 omalizumab injection (xolair) for asthma/allergy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Selter receive payments from pharmaceutical companies?
Yes. Dr. Selter received a total of $85,734 from 32 companies across 642 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Selter's costs compare to other opticians in Suffern?
Dr. Selter's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Selter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Suffern
Browse opticians in Suffern ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Grifols USA, LLC Payments to Doctors
See all physicians who received payments from Grifols USA, LLC.
By company
Circassia Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from Circassia Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology